题名 | NCIC CTG BR.26: A phase III randomized, double blind, placebo controlled trial of dacomitinib versus placebo in patients with advanced/metastatic non-small cell lung cancer (NSCLC) who received prior chemotherapy and an EGFR TKI |
链接 | http://meetinglibrary.asco.org/content/132768-144 |
本帖最后由 Ulipristal 于 2014-7-18 21:06 编辑
http://meetinglibrary.asco.org/content/132768-144
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |